214 related articles for article (PubMed ID: 37167276)
1. The stigma associated with cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL): A protocol for a systematic review.
Nuwangi H; Agampodi TC; Price HP; Shepherd T; Weerakoon KG; Agampodi SB
PLoS One; 2023; 18(5):e0285663. PubMed ID: 37167276
[TBL] [Abstract][Full Text] [Related]
2. Stigma associated with cutaneous and mucocutaneous leishmaniasis: A systematic review.
Nuwangi H; Agampodi TC; Price HP; Shepherd T; Weerakoon KG; Agampodi SB
PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011818. PubMed ID: 38153950
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
5. The leishmaniases in Kenya: A scoping review.
Grifferty G; Shirley H; O'Brien K; Hirsch JL; Orriols AM; Amechi KL; Lo J; Chanda N; El Hamzaoui S; Kahn J; Yap SV; Watson KE; Curran C; Atef AbdelAlim A; Bose N; Cilfone AL; Wamai R
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011358. PubMed ID: 37262045
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of allylamines in the treatment of cutaneous and mucocutaneous leishmaniasis: A systematic review.
Bezemer JM; van der Ende J; Limpens J; de Vries HJC; Schallig HDFH
PLoS One; 2021; 16(4):e0249628. PubMed ID: 33826660
[TBL] [Abstract][Full Text] [Related]
7. Exploring the cultural effects of gender on perceptions of cutaneous leishmaniasis: a systematic literature review.
Wenning B; Price H; Nuwangi H; Reda KT; Walters B; Ehsanullah R; Viana G; Andras A; Dikomitis L
Glob Health Res Policy; 2022 Sep; 7(1):34. PubMed ID: 36163191
[TBL] [Abstract][Full Text] [Related]
8. Vector and reservoir control for preventing leishmaniasis.
González U; Pinart M; Sinclair D; Firooz A; Enk C; Vélez ID; Esterhuizen TM; Tristan M; Alvar J
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008736. PubMed ID: 26246011
[TBL] [Abstract][Full Text] [Related]
9. Interventions for American cutaneous and mucocutaneous leishmaniasis.
Pinart M; Rueda JR; Romero GA; Pinzón-Flórez CE; Osorio-Arango K; Silveira Maia-Elkhoury AN; Reveiz L; Elias VM; Tweed JA
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004834. PubMed ID: 32853410
[TBL] [Abstract][Full Text] [Related]
10. Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal leishmaniasis: a systematic review and meta-analysis protocol.
Naeem F; Nathan K; Chivinski J; Ekmekjian T; Libman M; Barkati S
BMJ Open; 2021 Jun; 11(6):e045707. PubMed ID: 34135039
[TBL] [Abstract][Full Text] [Related]
11. Prognostic prediction models for clinical outcomes in patients diagnosed with visceral leishmaniasis: protocol for a systematic review.
Wilson J; Chowdhury F; Hassan S; Harriss EK; Alves F; Dahal P; Stepniewska K; Guérin PJ
BMJ Open; 2023 Oct; 13(10):e075597. PubMed ID: 37879686
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.
Galvão EL; Rabello A; Cota GF
PLoS One; 2017; 12(10):e0186117. PubMed ID: 29016694
[TBL] [Abstract][Full Text] [Related]
13. Interventions to treat cutaneous leishmaniasis in children: A systematic review.
Uribe-Restrepo A; Cossio A; Desai MM; Dávalos D; Castro MDM
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006986. PubMed ID: 30550538
[TBL] [Abstract][Full Text] [Related]
14. Evaluating characteristics of PROSPERO records as predictors of eventual publication of non-Cochrane systematic reviews: a meta-epidemiological study protocol.
Ruano J; Gómez-García F; Gay-Mimbrera J; Aguilar-Luque M; Fernández-Rueda JL; Fernández-Chaichio J; Alcalde-Mellado P; Carmona-Fernandez PJ; Sanz-Cabanillas JL; Viguera-Guerra I; Franco-García F; Cárdenas-Aranzana M; Romero JLH; Gonzalez-Padilla M; Isla-Tejera B; Garcia-Nieto AV
Syst Rev; 2018 Mar; 7(1):43. PubMed ID: 29523200
[TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel Surveillance Network analysis.
Boggild AK; Caumes E; Grobusch MP; Schwartz E; Hynes NA; Libman M; Connor BA; Chakrabarti S; Parola P; Keystone JS; Nash T; Showler AJ; Schunk M; Asgeirsson H; Hamer DH; Kain KC;
J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31553455
[TBL] [Abstract][Full Text] [Related]
17. Leishmaniasis in Cameroon: what is known and is done so far? A protocol for systematic review.
Djune Yemeli L; Domche A; Nana Djeunga HC; Lenou Nanga CG; Njih Tabah E; Nko'Ayissi GB; Kamgno J
BMJ Open; 2021 Apr; 11(4):e047530. PubMed ID: 33811058
[TBL] [Abstract][Full Text] [Related]
18. The Geographical Distribution of Human Cutaneous and Visceral
Hajjaran H; Saberi R; Borjian A; Fakhar M; Hosseini SA; Ghodrati S; Mohebali M
Front Public Health; 2021; 9():661674. PubMed ID: 34249836
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of Curcumin and its Derivatives as Valuable Sources of Antileishmanial Agents.
Albalawi AE; Alanazi AD; Sharifi I; Ezzatkhah F
Acta Parasitol; 2021 Sep; 66(3):797-811. PubMed ID: 33770343
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging medications for the treatment of leishmaniasis.
Chakravarty J; Sundar S
Expert Opin Pharmacother; 2019 Jul; 20(10):1251-1265. PubMed ID: 31063412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
